Cargando…

Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production

Numerous cell-based therapeutics are currently being tested in clinical trials. Human platelet lysate (HPL) is a valuable alternative to fetal bovine serum as a cell culture medium supplement for a variety of different cell types. HPL as a raw material permits animal serum-free cell propagation with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oeller, Michaela, Laner-Plamberger, Sandra, Krisch, Linda, Rohde, Eva, Strunk, Dirk, Schallmoser, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153614/ https://www.ncbi.nlm.nih.gov/pubmed/34068404 http://dx.doi.org/10.3390/ijms22105178

Ejemplares similares

Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate
por: Laner-Plamberger, Sandra, et al.
Publicado: (2019)

Transcription Factors STAT3 and MYC Are Key Players of Human Platelet Lysate-Induced Cell Proliferation
por: Oeller, Michaela, et al.
Publicado: (2022)

Heparin and Derivatives for Advanced Cell Therapies
por: Laner-Plamberger, Sandra, et al.
Publicado: (2021)

Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues
por: Laner-Plamberger, Sandra, et al.
Publicado: (2019)

Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
por: Gimona, Mario, et al.
Publicado: (2017)

Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate
por: Laner-Plamberger, Sandra, et al.
Publicado: (2015)

Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production
por: Krisch, Linda, et al.
Publicado: (2021)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022)

Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
por: Oeller, Michaela, et al.
Publicado: (2018)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration
por: Mareschi, Katia, et al.
Publicado: (2022)

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
por: Castiglia, Sara, et al.
Publicado: (2014)

An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles
por: Pachler, Karin, et al.
Publicado: (2017)

Synergy of Human Platelet-Derived Extracellular Vesicles with Secretome Proteins Promotes Regenerative Functions
por: Gomes, Fausto Gueths, et al.
Publicado: (2022)

Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo
por: Warnecke, Athanasia, et al.
Publicado: (2020)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

Batch Effects during Human Bone Marrow Stromal Cell Propagation Prevail Donor Variation and Culture Duration: Impact on Genotype, Phenotype and Function
por: Brachtl, Gabriele, et al.
Publicado: (2022)

Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
por: Jo, Hye-Yeong, et al.
Publicado: (2020)

Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
por: Pham, Phuc Van, et al.
Publicado: (2014)

Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy
por: Blackford, Samuel J.I., et al.
Publicado: (2018)

Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering
por: Shanbhag, Siddharth, et al.
Publicado: (2020)

Antimicrobial Effects of Equine Platelet Lysate
por: Gordon, Julie, et al.
Publicado: (2021)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Food and Drink - Good Manufacturing Practice
por: Manning, Louise
Publicado: (2018)

Self-assembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration
por: Ebner-Peking, Patricia, et al.
Publicado: (2021)

Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling
por: Rohban, Rokhsareh, et al.
Publicado: (2013)

Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats
por: Zhang, Yi, et al.
Publicado: (2020)

Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis
por: Forstner, Désirée, et al.
Publicado: (2019)

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers
por: Shafa, Mehdi, et al.
Publicado: (2018)

Human platelet lysate as a replacement for fetal bovine serum in human corneal stromal keratocyte and fibroblast culture
por: Seidelmann, Nina, et al.
Publicado: (2021)

The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells
por: Siciliano, Camilla, et al.
Publicado: (2015)

Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
por: Wiesinger, Manuel, et al.
Publicado: (2017)

Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
por: François, Pauline, et al.
Publicado: (2021)

Good manufacturing practices for pharmaceuticals : a plan for total quality control
por: Willig, Sidney H., 1919-
Publicado: (1997)

Cytokines in equine platelet lysate and related blood products
por: Moellerberndt, Julia, et al.
Publicado: (2023)

Application of platelet-rich plasma and platelet lysate in the treatment of experimental lymphocutaneous sporotrichosi
por: Najafi, Elahe, et al.
Publicado: (2019)

A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance
por: Ketterl, Nina, et al.
Publicado: (2015)

Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same
por: Hagen, Alina, et al.
Publicado: (2022)

Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells
por: Jonsdottir-Buch, Sandra Mjoll, et al.
Publicado: (2013)

Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
por: Weidner, Lisa, et al.
Publicado: (2021)

The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices
por: Fabio, Petrelli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hhlontfit5rjv8vgju4bf7gp7